Taglich Brothers assumed coverage on shares of Catasys Inc. (NASDAQ:CATS) in a research report released on Wednesday morning. The brokerage issued a speculative buy rating and a $8.00 target price on the stock. Taglich Brothers also issued estimates for Catasys’ Q3 2017 earnings at ($0.16) EPS, Q4 2017 earnings at ($0.13) EPS, FY2017 earnings at ($0.89) EPS, Q1 2018 earnings at ($0.05) EPS, Q2 2018 earnings at ($0.05) EPS, Q3 2018 earnings at ($0.04) EPS, Q4 2018 earnings at ($0.04) EPS and FY2018 earnings at ($0.18) EPS.
CATS has been the subject of a number of other reports. Telsey Advisory Group assumed coverage on shares of Catasys in a research note on Wednesday. They issued a buy rating for the company. Zacks Investment Research raised shares of Catasys from a sell rating to a hold rating in a research note on Monday, August 7th.
Catasys (NASDAQ CATS) traded down 5.99% during mid-day trading on Wednesday, reaching $3.61. The company had a trading volume of 97,491 shares. Catasys has a 12 month low of $3.56 and a 12 month high of $14.00. The stock’s market cap is $57.36 million. The firm’s 50-day moving average price is $4.72 and its 200-day moving average price is $5.16.
Catasys (NASDAQ:CATS) last announced its earnings results on Tuesday, August 15th. The company reported ($0.23) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.20) by ($0.03). The company had revenue of $1.67 million for the quarter. Equities research analysts forecast that Catasys will post ($1.14) EPS for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: This news story was originally reported by Markets Daily and is the sole property of of Markets Daily. If you are accessing this news story on another domain, it was stolen and republished in violation of US and international trademark & copyright law. The original version of this news story can be accessed at https://www.themarketsdaily.com/2017/10/21/taglich-brothers-begins-coverage-on-catasys-inc-cats.html.
A number of hedge funds and other institutional investors have recently made changes to their positions in CATS. FNY Partners Fund LP acquired a new position in Catasys in the 2nd quarter worth $1,560,000. Kennedy Capital Management Inc. acquired a new position in shares of Catasys during the 2nd quarter worth about $1,385,000. Bard Associates Inc. acquired a new position in shares of Catasys during the 2nd quarter worth about $1,012,000. UBS Oconnor LLC acquired a new position in shares of Catasys during the 2nd quarter worth about $834,000. Finally, Perkins Capital Management Inc. acquired a new position in shares of Catasys during the 2nd quarter worth about $113,000. 7.16% of the stock is owned by hedge funds and other institutional investors.
Catasys Company Profile
Catasys, Inc provides data analytics based specialized behavioral health management and integrated treatment services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services. The companys OnTrak solution includes medical and psychosocial interventions; and a proprietary Web based clinical information platform and database, psychosocial programs, and integrated care coaching services.
Receive News & Ratings for Catasys Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys Inc. and related companies with MarketBeat.com's FREE daily email newsletter.